Linda Ray, MD

Juvenile idiopathic arthritis: Old disease, new tactics

Publish date: March 11, 2019

Beyond NSAIDs and disease-modifying antirheumatic drugs are now biologic agents and anti-interleukin drugs that can augment therapy.